The Effect of Late-onset Ventilator-associated Pneumonia
in Determining Patient Mortality.
Best practice interventions: How can you prevent ventilator-associated pneumonia
Prevention of ventilator-associated pneumonia
by oral decontamination: A prospective, randomized, double-blind, placebo-controlled study.
METHOD Published reports were reviewed for current evidence on the use of the ventilator bundle to prevent ventilator-associated pneumonia
, and education sessions were held to present the findings to 61 nurses in coronary care and surgical intensive care units.
2] level of reliability and decreased episodes of ventilator-associated pneumonia
(Resar et al.
Inglis et al reported that biofilms have been identified in endotracheal tubes of patients with ventilator-associated pneumonia
which includes research with 50 infectious diseases specialists and 51 critical care/internists physicians, analyzes the usage and uptake of antibiotics for the treatment of patients diagnosed with CABP and NP, including hospital-acquired pneumonia, healthcare-associated pneumonia, and ventilator-associated pneumonia
in the hospital setting.
(VAP) is one of the most common and severe hospital-adquired infections, and multidrugresistant gram-negative bacilli (MDR-GNB) constitute the main etiology in many countries.
It has been suggested that instillation of normal saline in conjunction with endotracheal suctioning may result in dispersion of contaminated adherent material into the lower respiratory tract, with the subsequent increased risk of nosocomial infection such as ventilator-associated pneumonia
The topics include microbial populations in oral biofilms, bacterial catabolism of salivary substrates, the role of the extracellular polysaccharides matrix in virulent oral biofilms, a holistic view of interspecies bacterial interactions within human dental plaque, biofilms in periodontal health and disease, oral biofilms as a reservoir for extra-oral pathogens: ventilator-associated pneumonia
, and probiotics as a possible tool in oral health care.
(VAP) continues to be a leading cause of morbidity and mortality in the nosocomial setting.
3) MRSA is the most frequent cause of ventilator-associated pneumonia
and the second highest cause of mortality in these critically ill patients.